Dror Ortho-Design Files S-1 for $13M Public Offering at Significant Premium, Pursues Nasdaq Listing
DROR has more than doubled off its 52-week low of $0.001.
Summary
Dror Ortho-Design, Inc. filed an S-1 registration statement for a public offering of up to $13.0 million in common stock and prefunded warrants at an assumed price of $4.13 per share, a substantial premium to its current trading price, contingent on a Nasdaq Capital Market listing.
Key Events · Financing and Capital Events · DROR
-
Public Offering Announced
Dror Ortho-Design, Inc. is offering up to 3,636,364 shares of common stock or prefunded warrants, plus 254,545 underwriter warrants, with estimated net proceeds of $13.0 million (up to $15.0 million with over-allotment).
-
Significant Premium Pricing
The assumed public offering price is $4.13 per share, a substantial premium compared to the current OTC Pink market price of $0.0052 per share.
-
Nasdaq Listing Contingency
The offering is contingent upon the company's common stock being approved for listing on the Nasdaq Capital Market under the symbol 'DROR'.
-
Reverse Stock Split Planned
The company expects to effect a 1-for-550 reverse stock split prior to or upon the effectiveness of the registration statement, likely to meet Nasdaq listing requirements.
Analysis · DROR · Industrial Applications And Services
Dror Ortho-Design, Inc. has filed an S-1 registration statement for a public offering aiming to raise approximately $13.0 million (net proceeds), which is a substantial capital infusion for a company with a current market capitalization of $5.08 million. The offering is priced at an assumed $4.13 per share, representing a massive premium over its current OTC Pink market price of $0.0052. This significant pricing, coupled with the company's application to list on the Nasdaq Capital Market, indicates a potential re-rating of the stock and a major step towards improving its financial stability. The offering is contingent on Nasdaq listing approval, and the company plans a 1-for-550 reverse stock split to meet listing requirements. This capital raise is critical for Dror Ortho-Design, which has a going concern warning and insufficient liquidity, and follows its recent FDA 510(k) clearance for the ZSmile Platform. While the offering will result in substantial dilution (over 200% based on shares offered relative to current outstanding shares post-split), the ability to secure such a large amount of capital at a premium valuation, and the potential uplisting to Nasdaq, are overwhelmingly positive developments for the company's long-term viability and growth prospects.
How filings like this one have moved
In the 30 days to Sep 14, 2026, 41.1% of the 372 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.38%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, DROR was trading at $0.01 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $5.1M. The 52-week trading range was $0.00 to $0.04. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.